MedTrace Logo

Fecal Microbiota Transplant for Neuroblastoma in a Single Patient

NCT07223606 · Status: NO_LONGER_AVAILABLE · Type: EXPANDED_ACCESS

Last updated 2025-11-03

No results posted yet for this study

Summary

This study uses fecal microbiota transplant (FMT) to correct gut microbiome dysbiosis prior to and during standard-of-care neuroblastoma treatment

Conditions

  • Neuroblastoma
  • Neuroblastoma (NB)
  • Neuroblastoma (NBL)
  • Neuroblastoma (Measurable Disease)
  • Neuroblastoma Recurrent
  • Neuroblastoma in Children
  • Neuroblastoma. CNS

Interventions

BIOLOGICAL

Fecal Microbial Transplantation

This study will utilize donor stool from an infant

Sponsors & Collaborators

  • Microbiome Research Foundation

    collaborator OTHER

  • ProgenaBiome

    lead OTHER

Eligibility

Min Age
5 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07223606 on ClinicalTrials.gov